We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
+10.16%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$3.47B
AUM Growth
+$276M
Cap. Flow
+$43.8M
Cap. Flow %
1.26%
Top 10 Hldgs %
17.35%
Holding
336
New
19
Increased
143
Reduced
127
Closed
19

Top Buys

Rank Stock Value
1
SNPS icon
Synopsys
SNPS
+$18M
2
CDNS icon
Cadence Design Systems
CDNS
+$17.7M
3
BILL icon
BILL Holdings
BILL
+$12.1M
4
TALO icon
Talos Energy
TALO
+$10M
5
FTAI icon
FTAI Aviation
FTAI
+$9.83M

Top Sells

Rank Stock Value
1
TCBI icon
Texas Capital Bancshares
TCBI
+$11.9M
2
NWE icon
NorthWestern Energy
NWE
+$11.5M
3
CNOB icon
Center Bancorp
CNOB
+$10.9M
4
VBTX
Veritex Holdings
VBTX
+$10.7M
5
SFM icon
Sprouts Farmers Market
SFM
+$9.26M

Sector Composition

Rank Sector Weight
1 Technology 22.02%
2 Healthcare 17.94%
3 Financials 14.72%
4 Consumer Discretionary 13.46%
5 Industrials 12.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RAMP icon
226
LiveRamp
RAMP
$2.3B
$6.61M 0.19%
301,207
+7,881
+3% +$188K
SYNA icon
227
Synaptics
SYNA
$4.3B
$6.59M 0.19%
59,326
-12,957
-18% -$1.49M
GTN icon
228
Gray Television
GTN
$486M
$6.59M 0.19%
755,206
-35,280
-4% -$393K
PAR icon
229
PAR Technology
PAR
$701M
$6.48M 0.19%
190,669
+5,652
+3% +$188K
INSM icon
230
Insmed
INSM
$29.4B
$6.17M 0.18%
361,647
+10,678
+3% +$207K
SRI icon
231
Stoneridge
SRI
$203M
$6.09M 0.18%
325,535
-14,548
-4% -$312K
RARE icon
232
Ultragenyx Pharmaceutical
RARE
$2.59B
$5.96M 0.17%
148,687
+4,381
+3% +$188K
OPLN
233
Openlane
OPLN
$4.31B
$5.92M 0.17%
432,717
+13,037
+3% +$181K
MNRO icon
234
Monro
MNRO
$357M
$5.73M 0.17%
115,830
+3,425
+3% +$170K
ASTE icon
235
Astec Industries
ASTE
$972M
$5.41M 0.16%
+131,259
New +$5.54M
APPS icon
236
Digital Turbine
APPS
$1.52B
$5.4M 0.16%
436,615
-20,331
-4% -$273K
IONS icon
237
Ionis Pharmaceuticals
IONS
$9.33B
$5.33M 0.15%
149,247
+17,536
+13% +$658K
AZTA icon
238
Azenta
AZTA
$1.45B
$5.33M 0.15%
119,439
+3,538
+3% +$175K
BV icon
239
BrightView Holdings
BV
$1.05B
$5.16M 0.15%
917,772
+119,311
+15% +$805K
RBA icon
240
RB Global
RBA
$16.1B
$4.81M 0.14%
+85,448
New +$5.04M
SWTX
241
DELISTED
SpringWorks Therapeutics
SWTX
$4.36M 0.13%
169,543
+5,002
+3% +$146K
VRAY
242
DELISTED
ViewRay, Inc.
VRAY
$4.14M 0.12%
1,196,945
+35,483
+3% +$150K
ADPT icon
243
Adaptive Biotechnologies
ADPT
$3.99B
$4.13M 0.12%
467,395
+199,764
+75% +$1.76M
UEIC icon
244
Universal Electronics
UEIC
$74.6M
$2.69M 0.08%
265,705
-12,308
-4% -$214K
NVCR icon
245
NovoCure
NVCR
$2.04B
$2.41M 0.07%
40,095
+7,183
+22% +$574K
IOVA icon
246
Iovance Biotherapeutics
IOVA
$2.92B
$1.84M 0.05%
301,068
+8,903
+3% +$61.4K
MANH icon
247
Manhattan Associates
MANH
$11B
$1.52M 0.04%
9,810
-3,197
-25% -$440K
FSLR icon
248
First Solar
FSLR
$25B
$1.34M 0.04%
6,148
-2,889
-32% -$527K
WST icon
249
West Pharmaceutical
WST
$24.6B
$1.23M 0.04%
3,539
-1,150
-25% -$336K
NOVT icon
250
Novanta
NOVT
$6.36B
$1.22M 0.04%
7,683
-2,498
-25% -$384K
8 9
10
11 12

Similar funds

CAM
Contour Asset Management New York $3.08B AUM 21.94% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
SAG
Susquehanna Advisors Group Bala Cynwyd, Pennsylvania $3.05B AUM 41.49% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Peregrine Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Peregrine Capital Management held 336 positions worth $3.47B, up 8.7% from $3.19B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Peregrine Capital Management's Q1 2023 filing shows 19 new, 143 increased, 127 reduced and 19 closed positions. Its largest new stake was Synopsys: 50,490 shares worth $19.5M. The largest sale was Texas Capital Bancshares, an estimated $11.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Peregrine Capital Management's largest Q1 2023 buy was Synopsys: 50,490 shares worth $19.5M.
  • Peregrine Capital Management added most to BILL Holdings in Q1 2023, an estimated $12.1M increase.
  • Peregrine Capital Management's biggest Q1 2023 reduction was Texas Capital Bancshares, cutting an estimated $11.9M.
  • Peregrine Capital Management fully exited NorthWestern Energy in Q1 2023, selling an estimated $11.5M.
  • Peregrine Capital Management's ten largest holdings make up 17% of its $3.47B portfolio in Q1 2023.
  • Peregrine Capital Management opened 19 new positions and closed 19 in Q1 2023.
  • Peregrine Capital Management's portfolio value rose 8.7% quarter-over-quarter to $3.47B.

Based on Peregrine Capital Management's 13F filing for Q1 2023, filed 26 Apr 2023.